Logo

Hologic’s Genius Digital Diagnostics System Receives the US FDA’s Clearance to Identify Pre-Cancerous Lesions

Share this
Hologic

Hologic’s Genius Digital Diagnostics System Receives the US FDA’s Clearance to Identify Pre-Cancerous Lesions

Shots:

  • The US FDA has cleared Hologic's Genius Digital Diagnostics System that links AI with volumetric imaging technology to diagnose pre-cancerous lesions and cervical cancer cells. It is available in the EU, Australia & New Zealand while its US commercial availability is anticipated in early 2024
  • The system includes Genius Digital Imager for acquiring images, Genius Cervical AI algorithm to analyze images, Genius Image Management Server for storing images and Genius Review Station for reviewing local or remote cases
  • Moreover, unlike conventional pap tests, this system screens the patient's samples digitally using an AI algorithm to identify the cells to be reviewed by cytologists and pathologists

Ref: Hologic | Image: Hologic

Related News:- Vistagen Reports P-III Trial (PALISADE-2) Results of Fasedienol (PH94B) Nasal Spray for Social Anxiety Disorder

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Shivani Chandra

Shivani was a content writer at PharmaShots. She has a keen interest in recent innovations in the life sciences industry. She was covering news related to Product approvals, clinical trial results, and updates. We can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions